Related Experiment Video
Updated: Mar 26, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
Published on: January 17, 2012
Reduced secretion and altered proteolytic processing caused by missense mutations in progranulin
Gernot Kleinberger1, Anja Capell2, Nathalie Brouwers3
1Biochemistry, Biomedical Center (BMC), Ludwig-Maximilians University, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Molecular Genetics, Neurodegenerative Brain Diseases Group, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
New progranulin (GRN) missense mutations were identified in a frontotemporal lobar degeneration patient. These GRN variants reduce protein secretion and may act as low-penetrant risk factors for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Progranulin (GRN) is a secreted growth factor crucial for cellular functions.
- Loss-of-function mutations in GRN are a primary cause of frontotemporal lobar degeneration (FTLD) with TDP-43 pathology.
- While nonsense mutations reduce GRN expression, the pathogenicity of missense mutations remains unclear.
Purpose of the Study:
- To investigate the functional impact of novel GRN missense mutations.
- To determine if identified GRN variants contribute to neurodegenerative disease risk.
Main Methods:
- Identified a double missense mutation (p.D33E/p.G35R) in an FTLD patient.
- Analyzed the secretion efficiency and protein processing of GRN variants (p.D33E/p.G35R, p.C105R, p.V514M) using biochemical and cell biological methods.
Main Results:
- The GRN p.D33E/p.G35R and p.C105R variants exhibited reduced secretion efficiency.
- Loss of a conserved cysteine residue (p.C105R) impaired protein folding and altered proteolytic processing.
- Identified GRN variants may lead to partial loss-of-function.
Conclusions:
- The identified GRN missense mutations can impair protein secretion and processing.
- These variants may represent low-penetrant risk factors for neurodegenerative diseases, distinct from null mutations.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

